StemBond Technologies
1 known investors
StemBond makes SENCE, a range of cell culture well plates (6 to 96 wells), coverslips and inserts pre-coated with a proprietary animal-free hydrogel tuned to tissue-relevant stiffnesses. The synthetic, xeno-free surfaces are sold as reorderable consumables to researchers and biotechs to reduce variability and improve reproducibility in standard cell culture workflows.
Investors · 1
Frequently asked questions
- What does StemBond Technologies do?
- StemBond makes SENCE, a range of cell culture well plates (6 to 96 wells), coverslips and inserts pre-coated with a proprietary animal-free hydrogel tuned to tissue-relevant stiffnesses. The synthetic, xeno-free surfaces are sold as reorderable consumables to researchers and biotechs to reduce variability and improve reproducibility in standard cell culture workflows.
- Who are StemBond Technologies's investors?
- StemBond Technologies's investors include Start Codon.